IGF1 and major depressive disorder: Considering these roles, as well as IGF-1’s ability to suppress neuroinflammation [31], it has been hypothesized that the impairment of IGF-1 functions could be responsible for some clinical alterations observed in MDD patients, including cognitive compromission [31].